[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bausch Health Companies Inc (BHC.TO)

Bausch Health Companies Inc (BHC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 3,609,009
  • Shares Outstanding, K 373,991
  • Annual Sales, $ 10,266 M
  • Annual Income, $ 157,000 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.96
  • Price/Sales 0.24
  • Price/Cash Flow 1.43
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 48.29% (-1.97%)
  • Historical Volatility 91.91%
  • IV Percentile 36%
  • IV Rank 29.30%
  • IV High 111.17% on 08/15/25
  • IV Low 22.24% on 08/14/25
  • Expected Move (DTE 4) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.23
  • Today's Volume 1,317
  • Volume Avg (30-Day) 285
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 15,188
  • Open Int (30-Day) 14,045
  • Expected Range 9.65 to 9.65

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $1.42
  • Number of Estimates 2
  • High Estimate $1.47
  • Low Estimate $1.37
  • Prior Year $1.60
  • Growth Rate Est. (year over year) -11.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.10 +58.20%
on 07/21/26
9.69 -0.41%
on 07/31/26
+2.66 (+38.05%)
since 06/30/26
3-Month
6.10 +58.20%
on 07/21/26
9.69 -0.41%
on 07/31/26
+1.86 (+23.88%)
since 04/30/26
52-Week
6.10 +58.20%
on 07/21/26
11.97 -19.38%
on 08/15/25
+0.80 (+9.04%)
since 07/30/25

Most Recent Stories

More News
Bausch: Q2 Earnings Snapshot

Bausch: Q2 Earnings Snapshot

BHC.TO : 9.65 (+14.47%)
Stocks in play: Bausch Health Companies Inc.

Announces that PrELIDEL® (pimecrolimus) cream is now listed under Alberta's public drug plan for eligible ...

BHC.TO : 9.65 (+14.47%)
Stocks in play: Bausch Health Companies Inc.

Will release second-quarter 2026 financial results after market close on Wednesday, July 29. Bausch ...

BHC.TO : 9.65 (+14.47%)
Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China

Thermage ® , a pioneer in non-invasive skin tightening,  was awarded the AAA Well-Known Trademark Certification, the highest recognition in China's domestic...

BHC.TO : 9.65 (+14.47%)
BHC : 7.00 (+1.60%)
Stocks Tail off on World Concerns

Equities in Canada’s largest centre took it on the chin to begin a short week on Tuesday, as the toll ...

BHC.TO : 9.65 (+14.47%)
Bausch Health Announces 2026 Annual Meeting of Shareholder Results

LAVAL, QC , May 19, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that shareholders elected all 10 director nominees at its 2026 Annual Meeting of Shareholders...

BHC.TO : 9.65 (+14.47%)
BHC : 7.00 (+1.60%)
TSX Pops on Descending Oil Prices

Canada's main stock index rose on Thursday and was on track for monthly gains as oil prices pulled back ...

BHC.TO : 9.65 (+14.47%)
Bausch: Q1 Earnings Snapshot

Bausch: Q1 Earnings Snapshot

BHC.TO : 9.65 (+14.47%)
Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering

The skin recovery emulsion for dry, sensitive, or stressed skin is now available through select online channels

BHC.TO : 9.65 (+14.47%)
BHC : 7.00 (+1.60%)
TSX Pushes into Plus Column

Equity markets in Canada’s largest centre went tentatively into the green on Tuesday as investors monitored ...

BHC.TO : 9.65 (+14.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Relative Strength just crossed above 80%. The market has entered extreme overbought territory.

See More Share

Business Summary

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical;...

See More

Key Turning Points

3rd Resistance Point 11.40
2nd Resistance Point 10.54
1st Resistance Point 10.10
Last Price 9.65
1st Support Level 8.80
2nd Support Level 7.94
3rd Support Level 7.50

See More

52-Week High 11.97
Fibonacci 61.8% 9.73
Last Price 9.65
Fibonacci 50% 9.03
Fibonacci 38.2% 8.34
52-Week Low 6.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.